Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 11;5(2):e439. doi: 10.1212/NXI.0000000000000439. eCollection 2018 Mar.

¹ Department of Clinical Neurosciences (A.F.H., V.G., A.K., R.D.P.), Department of Oncology (A.F.H., R.d.M.), and Department of Radiology (P.H.), CHUV University Hospital & University of Lausanne, Switzerland.

No abstract available